Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mikel Lipschitz
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Predicting Successful Conservative Surgery After Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Journal of Breast Disease
Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy
World Journal of Surgical Oncology
Surgery
Oncology
Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer
Tumor Biology
Medicine
Cancer Research
The Immune Microenvironment of Breast Cancer Progression
Cancers
Cancer Research
Oncology
Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
Clinical Medicine Insights: Oncology
Oncology
Therapeutically Targeting Tumor Microenvironment–mediated Drug Resistance in Estrogen Receptor–positive Breast Cancer
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Local Estrogen Axis in the Human Bone Microenvironment Regulates Estrogen Receptor-Positive Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
BCT Score Predicts Chemotherapy Benefit in Asian Patients With Hormone Receptor-Positive, HER2-negative, Lymph Node-Negative Breast Cancer
PLoS ONE
Multidisciplinary
Factors Determining Anthracycline Use in Hormone Receptor Positive, Early Stage Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology